Large gap with delayed quotes
|
Last quote
03/12/2025 -
17:38:37
|
Bid
03/12/2025 -
17:29:57
|
Bid Volume |
Ask
03/12/2025 -
17:29:59
|
Ask Volume |
|---|---|---|---|---|
|
44.56
+0.06
(
+0.13% )
|
44.67
|
40 |
44.71
|
121 |
Analysis date: 11.03.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 14.02.2025.
Interest
Weak
Weak
Two stars since 14.02.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 03.12.2024 at a price of 44.43.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded below its moving average since 14.02.2025.
4wk Rel Perf
-2.87%
-2.87%
The four-week dividend-adjusted underperformance versus STOXX600 is 2.87%.
Sensibility
Middle
Middle
Moderate, no change over 1 year.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.31%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.61%.
Mkt Cap in $bn
14.25
14.25
With a market capitalization >$8bn, FRESENIUS MED.CARE is considered a large-cap stock.
G/PE Ratio
1.62
1.62
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
8.96
8.96
The estimated PE is for the year 2027.
LT Growth
11.12%
11.12%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
15
15
Over the last seven weeks, an average of 15 analysts provided earnings per share estimates.
Dividend Yield
3.42%
3.42%
The twelve month estimated dividend yield represents 30.66% of earnings forecasts.
Beta
80
80
For 1% of index variation, the stock varies on average by 0.80%.
Correlation
0.29
0.29
Stock movements are strongly independent of index variations.
Value at Risk
6.17
6.17
The value at risk is estimated at EUR 6.17. The risk is therefore 13.87%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002